Multiplexed high content screening assays create a systems cell biology approach to drug discovery
- 31 August 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Technologies
- Vol. 2 (2), 149-154
- https://doi.org/10.1016/j.ddtec.2005.05.023
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small MoleculesPLoS Biology, 2005
- Building and breeding molecules to spy on cells and tumorsFEBS Letters, 2004
- High-Content Screening with siRNA Optimizes a Cell Biological Approach to Drug Discovery: Defining the Role of P53 Activation in the Cellular Response to Anticancer DrugsSLAS Discovery, 2004
- A Quantitative Cell-Based High-Content Screening Assay for the Epidermal Growth Factor Receptor-Specific Activation of Mitogen-Activated Protein KinaseASSAY and Drug Development Technologies, 2004
- Advances in High Content Screening for Drug DiscoveryASSAY and Drug Development Technologies, 2003
- Fluorescent-protein biosensors: New tools for drug discoveryTrends in Biotechnology, 1998
- High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery ProcessSLAS Discovery, 1997
- Measurement and manipulation of cytoskeletal dynamics in living cellsCurrent Opinion in Cell Biology, 1995
- Green Fluorescent Protein as a Marker for Gene ExpressionScience, 1994
- Fluorescently labelled molecules as probes of the structure and function of living cellsNature, 1980